From the Departments of Neurointerventional Radiology and Neurosurgery (T.P.M., J.A.G., B.M.H., C.M.C., F.C.T.), Emory University School of Medicine, Atlanta, Georgia.
From the Departments of Neurointerventional Radiology and Neurosurgery (T.P.M., J.A.G., B.M.H., C.M.C., F.C.T.), Emory University School of Medicine, Atlanta, Georgia
AJNR Am J Neuroradiol. 2019 Apr;40(4):694-698. doi: 10.3174/ajnr.A6010. Epub 2019 Mar 7.
Flow diversion is an established method to treat complex intracranial aneurysms. The natural history of flow-diversion treatment failure resulting in aneurysm remnants is not well-defined. We aimed to delineate the clinical and angiographic features of this entity.
Review of a prospectively maintained Pipeline Embolization Device data base from inception to October 2017 was performed for aneurysms that demonstrated residual filling on follow-up imaging. Procedural and follow-up clinical details were recorded. Independent, blinded, angiographic assessment of occlusion was performed on the basis of the O'Kelly-Marotta scale. Aggregated outcomes were analyzed using the Fisher exact and Mann-Whitney tests for categoric and continuous variables, respectively (statistical significance, α = .05).
During the study period, 283 sequential patients were treated; 87% (246/283) were women. The median patient age was 55 years (interquartile range, 47-65 years). Six-month follow-up imaging was available in 83.7% (237/283) of patients, which showed 62.4% (148/237) complete occlusion (class D, O'Kelly-Marotta grading scale). Adjunctive coiling ( = .06), on-label Pipeline Embolization Device use ( = .04), and multiple device constructs ( = .02) had higher rates of complete occlusion at 6 months. Aneurysm remnants were identified in 25 cases on long-term follow-up imaging (median, 16 months; interquartile range, 12-24 months). No patient with an aneurysm remnant after flow diversion presented with delayed rupture or other clinical sequelae, with a median clinical follow-up of 31 months (interquartile range, 23-33 months).
Aneurysm remnants after flow diversion are infrequent with minimal clinical impact. When appropriate, the presence of overlapping devices and possibly adjunctive coiling may result in higher rates of complete occlusion.
血流导向装置是治疗复杂颅内动脉瘤的一种已确立的方法。血流导向装置治疗失败导致动脉瘤残留的自然史尚不清楚。我们旨在描绘这种情况的临床和血管造影特征。
对 2017 年 10 月前前瞻性维护的 Pipeline 栓塞装置数据库进行回顾性分析,以纳入在随访影像学上显示残留填充的动脉瘤。记录了手术和随访的临床细节。根据 O'Kelly-Marotta 分级标准,对闭塞程度进行独立、盲法、血管造影评估。使用 Fisher 精确检验和 Mann-Whitney U 检验分别对分类变量和连续变量进行汇总结果分析(统计学意义,α =.05)。
在研究期间,283 例连续患者接受了治疗;87%(246/283)为女性。患者的中位年龄为 55 岁(四分位间距,47-65 岁)。83.7%(237/283)的患者有 6 个月的随访影像学资料,其中 62.4%(148/237)显示完全闭塞(O'Kelly-Marotta 分级标准 D 级)。辅助线圈填塞( =.06)、符合适应证的 Pipeline 栓塞装置使用( =.04)和多个装置构建( =.02)在 6 个月时具有更高的完全闭塞率。在长期随访影像学上(中位数为 16 个月;四分位间距,12-24 个月)发现 25 例动脉瘤残留。在接受血流导向装置治疗后出现动脉瘤残留的患者中,无一例发生迟发性破裂或其他临床后遗症,中位临床随访时间为 31 个月(四分位间距,23-33 个月)。
血流导向装置治疗后动脉瘤残留较为少见,且临床影响较小。在适当情况下,重叠装置的存在和可能的辅助线圈填塞可能会导致更高的完全闭塞率。